Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alignment Healthcare (ALHC) EBITDA Margin (2020 - 2025)

Alignment Healthcare's EBITDA Margin history spans 6 years, with the latest figure at 0.24% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 211.0% year-over-year to 0.24%; the TTM value through Dec 2025 reached 1.13%, up 419.0%, while the annual FY2025 figure was 1.13%, 394.0% up from the prior year.
  • EBITDA Margin reached 0.24% in Q4 2025 per ALHC's latest filing, down from 1.58% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 2.96% in Q2 2025 to a low of 18.34% in Q1 2021.
  • Average EBITDA Margin over 5 years is 5.93%, with a median of 5.79% recorded in 2023.
  • Peak YoY movement for EBITDA Margin: plummeted -2041bps in 2021, then surged 1117bps in 2022.
  • A 5-year view of EBITDA Margin shows it stood at 13.19% in 2021, then grew by 1bps to 13.08% in 2022, then soared by 43bps to 7.49% in 2023, then soared by 69bps to 2.35% in 2024, then skyrocketed by 90bps to 0.24% in 2025.
  • Per Business Quant, the three most recent readings for ALHC's EBITDA Margin are 0.24% (Q4 2025), 1.58% (Q3 2025), and 2.96% (Q2 2025).